Tumor Necrosis Factor-alpha Promotes Tumor Growth by Inducing Vascular Endothelial Growth Factor

REFERENCES

• Balkwill F, Charles K A, Mantovani A Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 2005;7:211–217.
   PubMed Web of Science ®Google Scholar
• Mantovani A, Pierotti MA. Cancer and inflammation: a complex relationship. Cancer Lett 2008;267:180–181.
   PubMed Web of Science ®Google Scholar
• Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860–867.
   PubMed Web of Science ®Google Scholar
• Pollard JW Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 2004;4:71–78.
   PubMed Web of Science ®Google Scholar
• Rollins BJ Inflammatory chemokines in cancer growth and progression. Eur J Cancer 2006;42:760–767.
   PubMed Web of Science ®Google Scholar
• Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science 1998;281:1305–1308.
   PubMed Web of Science ®Google Scholar
• Lejeune FJ, Ruegg C, Lienard D. Clinical applications of tnf-alpha in cancer. Curr Opin Immunol 1998;10:573–580.
   PubMed Web of Science ®Google Scholar
• Richmond A, Yang J, Su Y. The good and the bad of chemokines/chemokine receptors in melanoma. Pigment Cell Melanoma Res 2009;22:175–186.
   PubMed Web of Science ®Google Scholar
• Szlosarek P, Charles KA, Balkwill FR. Tumour necrosis factor-alpha as a tumour promoter. Eur J Cancer 2006;42:745–750.
   PubMed Web of Science ®Google Scholar
• Folkman J. Angiogenesis. Annu Rev Med 2006;57:1–18.
   PubMed Web of Science ®Google Scholar
• Folkman J. Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov 2007;6:273–286.
   PubMed Web of Science ®Google Scholar
• Celerier J, Cruz A, Lamande N, Gasc JM, Corvol P. Angiotensinogen and its cleaved derivatives inhibit angiogenesis. Hypertension 2002;39:224–228.
   PubMed Web of Science ®Google Scholar
• Xie Y, Sheng W, Xiang J, Ye Z, Zhu Y, Chen X, Yang J. Recombinant human il-24 suppresses lung carcinoma cell growth via induction of cell apoptosis and inhibition of tumor angiogenesis. Cancer Biother Radiopharm 2008;23:310–320.
   PubMed Web of Science ®Google Scholar
• Westra J, Brouwer E, Bos R, Posthumus MD, Doornbos-van der Meer B, Kallenberg CG, Limburg PC. Regulation of cytokine-induced hif-1alpha expression in rheumatoid synovial fibroblasts. Ann N Y Acad Sci 2007;1108:340–348.
   PubMed Web of Science ®Google Scholar
• Wang GL, Semenza GL. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 1995;270:1230–1237.
   PubMed Web of Science ®Google Scholar
• Yamashita K, Discher DJ, Hu J, Bishopric NH, Webster KA. Molecular regulation of the endothelin-1 gene by hypoxia. Contributions of hypoxia-inducible factor-1, activator protein-1, gata-2, and p300/cbp. J Biol Chem 2001;276:12645–12653.
   PubMed Web of Science ®Google Scholar
• Lejeune FJ Clinical use of tnf revisited: Improving penetration of anti-cancer agents by increasing vascular permeability. J Clin Invest 2002;110:433–435.
   PubMed Web of Science ®Google Scholar
• Patel PS, Yang S, Li A, Varney ML, Singh RK. Capsaicin regulates vascular endothelial cell growth factor expression by modulation of hypoxia inducing factor-1alpha in human malignant melanoma cells. J Cancer Res Clin Oncol 2002;128:461–468.
   PubMed Web of Science ®Google Scholar
• Spinella F, Rosano L, Di Castro V, Decandia S, Nicotra MR, Natali P.G, Bagnato A Endothelin-1 and endothelin-3 promote invasive behavior via hypoxia-inducible factor-1alpha in human melanoma cells. Cancer Res 2007;67:1725–1734.
   PubMed Web of Science ®Google Scholar
• Lejeune FJ, Ghanem GE, Lienard D, Ewalenko P. An accurate method for cytostatic dosimetry in isolation perfusion based on limb vascular volume determination. Antibiot Chemother 1988;40:63–76.
   PubMedGoogle Scholar
• de Wilt JH, ten Hagen TL, de Boeck G, van Tiel ST, de Bruijn EA, Eggermont AM. Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusion. Br J Cancer 2000;82:1000–1003.
   PubMed Web of Science ®Google Scholar
• van der Veen AH, de Wilt JH, Eggermont AM, van Tiel ST, Seynhaeve AL, ten Hagen TL. Tnf-alpha augments intratumoural concentrations of doxorubicin in tnf-alpha-based isolated limb perfusion in rat sarcoma models and enhances anti-tumour effects. Br J Cancer 2000;82:973–980.
   PubMed Web of Science ®Google Scholar
• Micheau O, Tschopp J. Induction of tnf receptor i-mediated apoptosis via two sequential signaling complexes. Cell 2003;114: 181–190.
   PubMed Web of Science ®Google Scholar
• Li B, Vincent A, Cates J, Brantley-Sieders DM, Polk DB, Young P.P Low levels of tumor necrosis factor alpha increase tumor growth by inducing an endothelial phenotype of monocytes recruited to the tumor site. Cancer Res 2009;69:338–348.
   PubMed Web of Science ®Google Scholar
• Ozaki H, Yu A.Y, Della N, Ozaki K, Luna JD, Yamada H, Hackett SF, Okamoto N, Zack DJ, Semenza GL, Campochiaro P.A Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with vegf expression. Invest Ophthalmol Vis Sci 1999;40:182–189.
   PubMed Web of Science ®Google Scholar
• Guba M, Seeliger H, Kleespies A, Jauch KW, Bruns C. Vascular endothelial growth factor in colorectal cancer. Int J Colorectal Dis 2004;19:510–517.
   PubMed Web of Science ®Google Scholar
• Brychtova S, Bezdekova M, Brychta T, Tichy M. The role of vascular endothelial growth factors and their receptors in malignant melanomas. Neoplasma 2008;55:273–279.
   PubMed Web of Science ®Google Scholar
• Ryuto M, Ono M, Izumi H, Yoshida S, Weich H.A, Kohno K, Kuwano M Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells: possible roles of sp-1. J Biol Chem 1996;271:28220–28228.
   PubMed Web of Science ®Google Scholar
• Gaudry M, Bregerie O, Andrieu V, El Benna J, Pocidalo MA, Hakim J. Intracellular pool of vascular endothelial growth factor in human neutrophils. Blood 1997;90:4153– 4161.
   PubMed Web of Science ®Google Scholar
• Postovit LM, Seftor EA, Seftor RE, Hendrix MJ. Influence of the microenvironment on melanoma cell fate determination and phenotype. Cancer Res 2006;66:7833–7836.
   PubMedGoogle Scholar
• Giatromanolaki A, Sivridis E, Kouskoukis C, Gatter KC, Harris AL, Koukourakis MI. Hypoxia-inducible factors 1alpha and 2alpha are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skin. Melanoma Res 2003;13:493–501.
   PubMed Web of Science ®Google Scholar
• Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996;16:4604–4613.
   PubMed Web of Science ®Google Scholar
• Jensen RL, Ragel BT, Whang K, Gillespie D. Inhibition of hypoxia inducible factor-1alpha (hif-1alpha) decreases vascular endothelial growth factor (vegf) secretion and tumor growth in malignant gliomas. J Neurooncol 2006;78:233–247.
   PubMed Web of Science ®Google Scholar
• Albina JE, Mastrofrancesco B, Vessella JA, Louis CA, Henry WL Jr., Reichner JS Hif-1 expression in healing wounds: Hif-1alpha induction in primary inflammatory cells by tnf-alpha. Am J Physiol Cell Physiol 2001;281:C1971–1977.
   PubMed Web of Science ®Google Scholar
• Melnikova V.O, Bar-Eli M Inflammation and melanoma metastasis. Pigment Cell Melanoma Res 2009;22:257–267.
   PubMed Web of Science ®Google Scholar
• Hundsberger H, Verin A, Wiesner C, Pfluger M, Dulebo A, Schutt W, Lasters I, Mannel DN, Wendel A, Lucas R. Tnf: A moonlighting protein at the interface between cancer and infection. Front Biosci 2008;13:5374–5386.
   PubMed Web of Science ®Google Scholar